nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2C9—Vismodegib—skin cancer	0.105	0.262	CbGbCtD
Promethazine—ABCB1—Vismodegib—skin cancer	0.102	0.254	CbGbCtD
Promethazine—CYP2D6—Vemurafenib—skin cancer	0.0761	0.189	CbGbCtD
Promethazine—ABCB1—Dactinomycin—skin cancer	0.0537	0.133	CbGbCtD
Promethazine—CYP2C9—Fluorouracil—skin cancer	0.0374	0.093	CbGbCtD
Promethazine—ABCB1—Docetaxel—skin cancer	0.0277	0.0689	CbGbCtD
Promethazine—CHRM3—muscle of abdomen—skin cancer	0.0157	0.0816	CbGeAlD
Promethazine—HRH1—nose—skin cancer	0.0121	0.063	CbGeAlD
Promethazine—CHRM5—skin epidermis—skin cancer	0.0103	0.0534	CbGeAlD
Promethazine—CALM2—ear—skin cancer	0.0076	0.0395	CbGeAlD
Promethazine—CALM1—ear—skin cancer	0.00756	0.0393	CbGeAlD
Promethazine—Paralysis—Vemurafenib—skin cancer	0.00638	0.0261	CcSEcCtD
Promethazine—CALM2—nerve—skin cancer	0.00478	0.0249	CbGeAlD
Promethazine—HTR2A—hindlimb—skin cancer	0.00477	0.0248	CbGeAlD
Promethazine—CALM1—nerve—skin cancer	0.00476	0.0248	CbGeAlD
Promethazine—DRD2—nerve—skin cancer	0.0044	0.0229	CbGeAlD
Promethazine—HTR2A—appendage—skin cancer	0.00409	0.0213	CbGeAlD
Promethazine—CALM2—endothelium—skin cancer	0.00407	0.0212	CbGeAlD
Promethazine—CALM1—endothelium—skin cancer	0.00405	0.0211	CbGeAlD
Promethazine—CALM2—hair follicle—skin cancer	0.004	0.0208	CbGeAlD
Promethazine—CALM2—blood vessel—skin cancer	0.00376	0.0195	CbGeAlD
Promethazine—CALM1—blood vessel—skin cancer	0.00374	0.0195	CbGeAlD
Promethazine—Photosensitivity—Vemurafenib—skin cancer	0.00366	0.015	CcSEcCtD
Promethazine—CALM3—nipple—skin cancer	0.00346	0.018	CbGeAlD
Promethazine—CHRM5—epithelium—skin cancer	0.00334	0.0174	CbGeAlD
Promethazine—Necrosis—Dactinomycin—skin cancer	0.00319	0.013	CcSEcCtD
Promethazine—CHRM5—skin of body—skin cancer	0.00318	0.0165	CbGeAlD
Promethazine—Swelling—Imiquimod—skin cancer	0.00311	0.0127	CcSEcCtD
Promethazine—Extravasation—Bleomycin—skin cancer	0.00308	0.0126	CcSEcCtD
Promethazine—Muscle spasms—Vismodegib—skin cancer	0.00301	0.0123	CcSEcCtD
Promethazine—Nasal congestion—Imiquimod—skin cancer	0.00301	0.0123	CcSEcCtD
Promethazine—Extrapyramidal disorder—Temozolomide—skin cancer	0.00301	0.0123	CcSEcCtD
Promethazine—HTR2A—nerve—skin cancer	0.0029	0.0151	CbGeAlD
Promethazine—Extravasation—Dactinomycin—skin cancer	0.00287	0.0117	CcSEcCtD
Promethazine—CALM2—nipple—skin cancer	0.00272	0.0141	CbGeAlD
Promethazine—CALM1—nipple—skin cancer	0.0027	0.0141	CbGeAlD
Promethazine—CALM2—neck—skin cancer	0.00269	0.014	CbGeAlD
Promethazine—CALM1—neck—skin cancer	0.00267	0.0139	CbGeAlD
Promethazine—Necrosis—Fluorouracil—skin cancer	0.00266	0.0109	CcSEcCtD
Promethazine—CHRM4—head—skin cancer	0.00265	0.0138	CbGeAlD
Promethazine—Irritability—Imiquimod—skin cancer	0.00262	0.0107	CcSEcCtD
Promethazine—Urinary retention—Imiquimod—skin cancer	0.00261	0.0107	CcSEcCtD
Promethazine—Photosensitivity reaction—Vemurafenib—skin cancer	0.00254	0.0104	CcSEcCtD
Promethazine—HTR2A—endothelium—skin cancer	0.00247	0.0128	CbGeAlD
Promethazine—Sensory loss—Fluorouracil—skin cancer	0.00241	0.00985	CcSEcCtD
Promethazine—Extravasation—Fluorouracil—skin cancer	0.00239	0.00978	CcSEcCtD
Promethazine—Aplastic anaemia—Dactinomycin—skin cancer	0.00235	0.00962	CcSEcCtD
Promethazine—Coordination abnormal—Temozolomide—skin cancer	0.00231	0.00943	CcSEcCtD
Promethazine—HTR2A—blood vessel—skin cancer	0.00228	0.0118	CbGeAlD
Promethazine—Phlebitis—Bleomycin—skin cancer	0.00226	0.00925	CcSEcCtD
Promethazine—Dyspepsia—Vismodegib—skin cancer	0.00225	0.00921	CcSEcCtD
Promethazine—Decreased appetite—Vismodegib—skin cancer	0.00222	0.0091	CcSEcCtD
Promethazine—Fatigue—Vismodegib—skin cancer	0.00221	0.00902	CcSEcCtD
Promethazine—Pain—Vismodegib—skin cancer	0.00219	0.00895	CcSEcCtD
Promethazine—Constipation—Vismodegib—skin cancer	0.00219	0.00895	CcSEcCtD
Promethazine—Disorientation—Bleomycin—skin cancer	0.00218	0.00891	CcSEcCtD
Promethazine—Photosensitivity reaction—Imiquimod—skin cancer	0.00216	0.00885	CcSEcCtD
Promethazine—Aplastic anaemia—Temozolomide—skin cancer	0.00213	0.0087	CcSEcCtD
Promethazine—Phlebitis—Dactinomycin—skin cancer	0.00211	0.00863	CcSEcCtD
Promethazine—Depression—Imiquimod—skin cancer	0.00211	0.00862	CcSEcCtD
Promethazine—CHRM5—head—skin cancer	0.00207	0.0108	CbGeAlD
Promethazine—Dermatitis contact—Fluorouracil—skin cancer	0.00206	0.00844	CcSEcCtD
Promethazine—CALM3—mammalian vulva—skin cancer	0.00202	0.0105	CbGeAlD
Promethazine—HRH1—nipple—skin cancer	0.00197	0.0103	CbGeAlD
Promethazine—Erythema—Vemurafenib—skin cancer	0.00194	0.00792	CcSEcCtD
Promethazine—CALM2—connective tissue—skin cancer	0.00193	0.01	CbGeAlD
Promethazine—Necrosis—Docetaxel—skin cancer	0.00192	0.00785	CcSEcCtD
Promethazine—CALM1—connective tissue—skin cancer	0.00192	0.00997	CbGeAlD
Promethazine—Coma—Fluorouracil—skin cancer	0.00191	0.0078	CcSEcCtD
Promethazine—Thrombophlebitis—Temozolomide—skin cancer	0.0019	0.00777	CcSEcCtD
Promethazine—Asthenia—Vismodegib—skin cancer	0.00184	0.00751	CcSEcCtD
Promethazine—CALM2—epithelium—skin cancer	0.00183	0.00951	CbGeAlD
Promethazine—CALM1—epithelium—skin cancer	0.00182	0.00947	CbGeAlD
Promethazine—Pruritus—Vismodegib—skin cancer	0.00181	0.00741	CcSEcCtD
Promethazine—Nasal congestion—Temozolomide—skin cancer	0.0018	0.00738	CcSEcCtD
Promethazine—Euphoric mood—Fluorouracil—skin cancer	0.00179	0.00733	CcSEcCtD
Promethazine—Tinnitus—Imiquimod—skin cancer	0.00177	0.00724	CcSEcCtD
Promethazine—Diarrhoea—Vismodegib—skin cancer	0.00175	0.00716	CcSEcCtD
Promethazine—Thrombophlebitis—Fluorouracil—skin cancer	0.00175	0.00716	CcSEcCtD
Promethazine—CALM2—skin of body—skin cancer	0.00174	0.00905	CbGeAlD
Promethazine—CALM1—skin of body—skin cancer	0.00173	0.00901	CbGeAlD
Promethazine—Extravasation—Docetaxel—skin cancer	0.00173	0.00706	CcSEcCtD
Promethazine—Photosensitivity—Fluorouracil—skin cancer	0.00172	0.00706	CcSEcCtD
Promethazine—Swelling—Fluorouracil—skin cancer	0.00172	0.00702	CcSEcCtD
Promethazine—ADRA1A—epithelium—skin cancer	0.00171	0.00892	CbGeAlD
Promethazine—Arrhythmia—Imiquimod—skin cancer	0.0017	0.00693	CcSEcCtD
Promethazine—Disorientation—Fluorouracil—skin cancer	0.00169	0.00693	CcSEcCtD
Promethazine—Erythema—Imiquimod—skin cancer	0.00165	0.00676	CcSEcCtD
Promethazine—Diplopia—Temozolomide—skin cancer	0.00164	0.00672	CcSEcCtD
Promethazine—HTR2A—neck—skin cancer	0.00163	0.00848	CbGeAlD
Promethazine—Rash—Vismodegib—skin cancer	0.00161	0.0066	CcSEcCtD
Promethazine—Dermatitis—Vismodegib—skin cancer	0.00161	0.00659	CcSEcCtD
Promethazine—CALM2—mammalian vulva—skin cancer	0.00159	0.00825	CbGeAlD
Promethazine—Anaphylactic shock—Vemurafenib—skin cancer	0.00158	0.00647	CcSEcCtD
Promethazine—CALM1—mammalian vulva—skin cancer	0.00158	0.00821	CbGeAlD
Promethazine—CHRM1—female reproductive system—skin cancer	0.00155	0.00807	CbGeAlD
Promethazine—Agitation—Imiquimod—skin cancer	0.00152	0.00621	CcSEcCtD
Promethazine—Injection site reaction—Docetaxel—skin cancer	0.0015	0.00612	CcSEcCtD
Promethazine—ABCB1—blood vessel—skin cancer	0.00149	0.00776	CbGeAlD
Promethazine—Syncope—Imiquimod—skin cancer	0.00148	0.00606	CcSEcCtD
Promethazine—Hypotension—Vemurafenib—skin cancer	0.00148	0.00604	CcSEcCtD
Promethazine—Palpitations—Imiquimod—skin cancer	0.00146	0.00597	CcSEcCtD
Promethazine—Loss of consciousness—Imiquimod—skin cancer	0.00145	0.00594	CcSEcCtD
Promethazine—Irritability—Fluorouracil—skin cancer	0.00145	0.00591	CcSEcCtD
Promethazine—Convulsion—Imiquimod—skin cancer	0.00143	0.00586	CcSEcCtD
Promethazine—CHRM2—head—skin cancer	0.00142	0.0074	CbGeAlD
Promethazine—CALM2—lymphoid tissue—skin cancer	0.00141	0.00733	CbGeAlD
Promethazine—CALM1—lymphoid tissue—skin cancer	0.0014	0.00729	CbGeAlD
Promethazine—Anxiety—Imiquimod—skin cancer	0.0014	0.00573	CcSEcCtD
Promethazine—HRH1—connective tissue—skin cancer	0.0014	0.00727	CbGeAlD
Promethazine—CHRM3—female reproductive system—skin cancer	0.00139	0.00722	CbGeAlD
Promethazine—Dry mouth—Imiquimod—skin cancer	0.00138	0.00563	CcSEcCtD
Promethazine—Decreased appetite—Vemurafenib—skin cancer	0.00137	0.00562	CcSEcCtD
Promethazine—Fatigue—Vemurafenib—skin cancer	0.00136	0.00558	CcSEcCtD
Promethazine—CALM2—female reproductive system—skin cancer	0.00136	0.00707	CbGeAlD
Promethazine—CALM1—female reproductive system—skin cancer	0.00135	0.00703	CbGeAlD
Promethazine—Constipation—Vemurafenib—skin cancer	0.00135	0.00553	CcSEcCtD
Promethazine—Oedema—Imiquimod—skin cancer	0.00135	0.00552	CcSEcCtD
Promethazine—HRH1—epithelium—skin cancer	0.00133	0.00691	CbGeAlD
Promethazine—Shock—Imiquimod—skin cancer	0.00133	0.00543	CcSEcCtD
Promethazine—ADRA1A—lymphoid tissue—skin cancer	0.00132	0.00687	CbGeAlD
Promethazine—Tachycardia—Imiquimod—skin cancer	0.00132	0.00538	CcSEcCtD
Promethazine—Agranulocytosis—Dactinomycin—skin cancer	0.00131	0.00535	CcSEcCtD
Promethazine—Photosensitivity reaction—Temozolomide—skin cancer	0.0013	0.00531	CcSEcCtD
Promethazine—CHRM1—head—skin cancer	0.0013	0.00674	CbGeAlD
Promethazine—CYP2B6—skin of body—skin cancer	0.00129	0.00673	CbGeAlD
Promethazine—Phlebitis—Docetaxel—skin cancer	0.00127	0.00519	CcSEcCtD
Promethazine—Depression—Temozolomide—skin cancer	0.00126	0.00517	CcSEcCtD
Promethazine—Thrombophlebitis—Docetaxel—skin cancer	0.00126	0.00517	CcSEcCtD
Promethazine—Swelling—Docetaxel—skin cancer	0.00124	0.00507	CcSEcCtD
Promethazine—Insomnia—Imiquimod—skin cancer	0.00122	0.00499	CcSEcCtD
Promethazine—Somnolence—Imiquimod—skin cancer	0.0012	0.0049	CcSEcCtD
Promethazine—Photosensitivity reaction—Fluorouracil—skin cancer	0.00119	0.00489	CcSEcCtD
Promethazine—Dyspepsia—Imiquimod—skin cancer	0.00119	0.00485	CcSEcCtD
Promethazine—Erythema—Bleomycin—skin cancer	0.00117	0.0048	CcSEcCtD
Promethazine—Decreased appetite—Imiquimod—skin cancer	0.00117	0.00479	CcSEcCtD
Promethazine—HTR2A—connective tissue—skin cancer	0.00117	0.00608	CbGeAlD
Promethazine—Fatigue—Imiquimod—skin cancer	0.00116	0.00475	CcSEcCtD
Promethazine—CHRM3—head—skin cancer	0.00116	0.00603	CbGeAlD
Promethazine—Pain—Imiquimod—skin cancer	0.00115	0.00472	CcSEcCtD
Promethazine—HRH1—mammalian vulva—skin cancer	0.00115	0.00599	CbGeAlD
Promethazine—CALM2—head—skin cancer	0.00113	0.0059	CbGeAlD
Promethazine—Asthenia—Vemurafenib—skin cancer	0.00113	0.00464	CcSEcCtD
Promethazine—Hallucination—Temozolomide—skin cancer	0.00113	0.00463	CcSEcCtD
Promethazine—CALM1—head—skin cancer	0.00113	0.00588	CbGeAlD
Promethazine—Pruritus—Vemurafenib—skin cancer	0.00112	0.00458	CcSEcCtD
Promethazine—Feeling abnormal—Imiquimod—skin cancer	0.00111	0.00454	CcSEcCtD
Promethazine—HTR2A—epithelium—skin cancer	0.00111	0.00577	CbGeAlD
Promethazine—Erythema—Dactinomycin—skin cancer	0.00109	0.00448	CcSEcCtD
Promethazine—Agranulocytosis—Fluorouracil—skin cancer	0.00109	0.00446	CcSEcCtD
Promethazine—Diarrhoea—Vemurafenib—skin cancer	0.00108	0.00442	CcSEcCtD
Promethazine—ADRA1A—head—skin cancer	0.00106	0.00554	CbGeAlD
Promethazine—Tinnitus—Temozolomide—skin cancer	0.00106	0.00434	CcSEcCtD
Promethazine—Leukopenia—Bleomycin—skin cancer	0.00105	0.0043	CcSEcCtD
Promethazine—CYP2B6—lymphoid tissue—skin cancer	0.00105	0.00545	CbGeAlD
Promethazine—Dizziness—Vemurafenib—skin cancer	0.00105	0.00428	CcSEcCtD
Promethazine—DRD2—head—skin cancer	0.00104	0.00543	CbGeAlD
Promethazine—CALM3—lymph node—skin cancer	0.00101	0.00526	CbGeAlD
Promethazine—CYP2B6—female reproductive system—skin cancer	0.00101	0.00525	CbGeAlD
Promethazine—CYP2C9—female reproductive system—skin cancer	0.001	0.0052	CbGeAlD
Promethazine—Rash—Vemurafenib—skin cancer	0.000997	0.00408	CcSEcCtD
Promethazine—Dermatitis—Vemurafenib—skin cancer	0.000996	0.00407	CcSEcCtD
Promethazine—Headache—Vemurafenib—skin cancer	0.00099	0.00405	CcSEcCtD
Promethazine—Erythema—Temozolomide—skin cancer	0.00099	0.00405	CcSEcCtD
Promethazine—HRH1—female reproductive system—skin cancer	0.000986	0.00513	CbGeAlD
Promethazine—Leukopenia—Dactinomycin—skin cancer	0.00098	0.00401	CcSEcCtD
Promethazine—Asthenia—Imiquimod—skin cancer	0.000967	0.00396	CcSEcCtD
Promethazine—Confusional state—Bleomycin—skin cancer	0.000966	0.00395	CcSEcCtD
Promethazine—Oedema—Bleomycin—skin cancer	0.000958	0.00392	CcSEcCtD
Promethazine—Anaphylactic shock—Bleomycin—skin cancer	0.000958	0.00392	CcSEcCtD
Promethazine—Pruritus—Imiquimod—skin cancer	0.000954	0.0039	CcSEcCtD
Promethazine—Thrombocytopenia—Bleomycin—skin cancer	0.000938	0.00384	CcSEcCtD
Promethazine—Arrhythmia—Fluorouracil—skin cancer	0.000936	0.00383	CcSEcCtD
Promethazine—Vision blurred—Temozolomide—skin cancer	0.000933	0.00382	CcSEcCtD
Promethazine—Tremor—Temozolomide—skin cancer	0.000928	0.00379	CcSEcCtD
Promethazine—Diarrhoea—Imiquimod—skin cancer	0.000922	0.00377	CcSEcCtD
Promethazine—Erythema—Fluorouracil—skin cancer	0.000912	0.00373	CcSEcCtD
Promethazine—Agitation—Temozolomide—skin cancer	0.00091	0.00372	CcSEcCtD
Promethazine—Hypotension—Bleomycin—skin cancer	0.000895	0.00366	CcSEcCtD
Promethazine—Oedema—Dactinomycin—skin cancer	0.000893	0.00365	CcSEcCtD
Promethazine—Dizziness—Imiquimod—skin cancer	0.000892	0.00365	CcSEcCtD
Promethazine—Leukopenia—Temozolomide—skin cancer	0.000886	0.00362	CcSEcCtD
Promethazine—Palpitations—Temozolomide—skin cancer	0.000875	0.00358	CcSEcCtD
Promethazine—Thrombocytopenia—Dactinomycin—skin cancer	0.000875	0.00358	CcSEcCtD
Promethazine—Vision blurred—Fluorouracil—skin cancer	0.00086	0.00352	CcSEcCtD
Promethazine—Convulsion—Temozolomide—skin cancer	0.000858	0.00351	CcSEcCtD
Promethazine—Rash—Imiquimod—skin cancer	0.00085	0.00348	CcSEcCtD
Promethazine—Dermatitis—Imiquimod—skin cancer	0.000849	0.00347	CcSEcCtD
Promethazine—Headache—Imiquimod—skin cancer	0.000845	0.00346	CcSEcCtD
Promethazine—CYP2B6—head—skin cancer	0.000844	0.00439	CbGeAlD
Promethazine—Anxiety—Temozolomide—skin cancer	0.00084	0.00344	CcSEcCtD
Promethazine—Decreased appetite—Bleomycin—skin cancer	0.000833	0.00341	CcSEcCtD
Promethazine—Dry mouth—Temozolomide—skin cancer	0.000824	0.00337	CcSEcCtD
Promethazine—HRH1—head—skin cancer	0.000824	0.00429	CbGeAlD
Promethazine—HTR2A—female reproductive system—skin cancer	0.000824	0.00428	CbGeAlD
Promethazine—Jaundice—Docetaxel—skin cancer	0.000821	0.00336	CcSEcCtD
Promethazine—Pain—Bleomycin—skin cancer	0.000819	0.00335	CcSEcCtD
Promethazine—Leukopenia—Fluorouracil—skin cancer	0.000816	0.00334	CcSEcCtD
Promethazine—Confusional state—Temozolomide—skin cancer	0.000815	0.00333	CcSEcCtD
Promethazine—Oedema—Temozolomide—skin cancer	0.000808	0.00331	CcSEcCtD
Promethazine—Anaphylactic shock—Temozolomide—skin cancer	0.000808	0.00331	CcSEcCtD
Promethazine—CALM2—lymph node—skin cancer	0.000795	0.00413	CbGeAlD
Promethazine—Thrombocytopenia—Temozolomide—skin cancer	0.000791	0.00324	CcSEcCtD
Promethazine—CALM1—lymph node—skin cancer	0.000791	0.00411	CbGeAlD
Promethazine—Convulsion—Fluorouracil—skin cancer	0.00079	0.00323	CcSEcCtD
Promethazine—Feeling abnormal—Bleomycin—skin cancer	0.000789	0.00323	CcSEcCtD
Promethazine—Agranulocytosis—Docetaxel—skin cancer	0.000786	0.00322	CcSEcCtD
Promethazine—Decreased appetite—Dactinomycin—skin cancer	0.000777	0.00318	CcSEcCtD
Promethazine—Fatigue—Dactinomycin—skin cancer	0.00077	0.00315	CcSEcCtD
Promethazine—Pain—Dactinomycin—skin cancer	0.000764	0.00312	CcSEcCtD
Promethazine—Confusional state—Fluorouracil—skin cancer	0.000751	0.00307	CcSEcCtD
Promethazine—CYP2D6—female reproductive system—skin cancer	0.00075	0.0039	CbGeAlD
Promethazine—Anaphylactic shock—Fluorouracil—skin cancer	0.000744	0.00305	CcSEcCtD
Promethazine—Oedema—Fluorouracil—skin cancer	0.000744	0.00305	CcSEcCtD
Promethazine—Feeling abnormal—Dactinomycin—skin cancer	0.000736	0.00301	CcSEcCtD
Promethazine—Insomnia—Temozolomide—skin cancer	0.000731	0.00299	CcSEcCtD
Promethazine—Thrombocytopenia—Fluorouracil—skin cancer	0.000729	0.00298	CcSEcCtD
Promethazine—Tachycardia—Fluorouracil—skin cancer	0.000727	0.00297	CcSEcCtD
Promethazine—ABCB1—epithelium—skin cancer	0.000727	0.00378	CbGeAlD
Promethazine—Somnolence—Temozolomide—skin cancer	0.000718	0.00294	CcSEcCtD
Promethazine—Dyspepsia—Temozolomide—skin cancer	0.000711	0.00291	CcSEcCtD
Promethazine—Decreased appetite—Temozolomide—skin cancer	0.000702	0.00287	CcSEcCtD
Promethazine—Fatigue—Temozolomide—skin cancer	0.000697	0.00285	CcSEcCtD
Promethazine—Hypotension—Fluorouracil—skin cancer	0.000696	0.00285	CcSEcCtD
Promethazine—Pain—Temozolomide—skin cancer	0.000691	0.00283	CcSEcCtD
Promethazine—Constipation—Temozolomide—skin cancer	0.000691	0.00283	CcSEcCtD
Promethazine—HTR2A—head—skin cancer	0.000688	0.00358	CbGeAlD
Promethazine—Asthenia—Bleomycin—skin cancer	0.000687	0.00281	CcSEcCtD
Promethazine—Pruritus—Bleomycin—skin cancer	0.000678	0.00277	CcSEcCtD
Promethazine—Arrhythmia—Docetaxel—skin cancer	0.000676	0.00276	CcSEcCtD
Promethazine—Insomnia—Fluorouracil—skin cancer	0.000673	0.00275	CcSEcCtD
Promethazine—Feeling abnormal—Temozolomide—skin cancer	0.000666	0.00272	CcSEcCtD
Promethazine—Somnolence—Fluorouracil—skin cancer	0.000662	0.00271	CcSEcCtD
Promethazine—Erythema—Docetaxel—skin cancer	0.000658	0.00269	CcSEcCtD
Promethazine—Dyspepsia—Fluorouracil—skin cancer	0.000655	0.00268	CcSEcCtD
Promethazine—Decreased appetite—Fluorouracil—skin cancer	0.000647	0.00265	CcSEcCtD
Promethazine—Asthenia—Dactinomycin—skin cancer	0.000641	0.00262	CcSEcCtD
Promethazine—Pain—Fluorouracil—skin cancer	0.000637	0.0026	CcSEcCtD
Promethazine—Muscle spasms—Docetaxel—skin cancer	0.000633	0.00259	CcSEcCtD
Promethazine—ABCB1—mammalian vulva—skin cancer	0.00063	0.00328	CbGeAlD
Promethazine—CYP2D6—head—skin cancer	0.000627	0.00326	CbGeAlD
Promethazine—Feeling abnormal—Fluorouracil—skin cancer	0.000613	0.00251	CcSEcCtD
Promethazine—Diarrhoea—Dactinomycin—skin cancer	0.000611	0.0025	CcSEcCtD
Promethazine—Rash—Bleomycin—skin cancer	0.000604	0.00247	CcSEcCtD
Promethazine—Dermatitis—Bleomycin—skin cancer	0.000603	0.00247	CcSEcCtD
Promethazine—Syncope—Docetaxel—skin cancer	0.00059	0.00242	CcSEcCtD
Promethazine—Leukopenia—Docetaxel—skin cancer	0.000589	0.00241	CcSEcCtD
Promethazine—Palpitations—Docetaxel—skin cancer	0.000582	0.00238	CcSEcCtD
Promethazine—Asthenia—Temozolomide—skin cancer	0.00058	0.00237	CcSEcCtD
Promethazine—Loss of consciousness—Docetaxel—skin cancer	0.000579	0.00237	CcSEcCtD
Promethazine—HRH1—lymph node—skin cancer	0.000577	0.003	CbGeAlD
Promethazine—Pruritus—Temozolomide—skin cancer	0.000572	0.00234	CcSEcCtD
Promethazine—Convulsion—Docetaxel—skin cancer	0.00057	0.00233	CcSEcCtD
Promethazine—Rash—Dactinomycin—skin cancer	0.000563	0.0023	CcSEcCtD
Promethazine—ABCB1—lymphoid tissue—skin cancer	0.00056	0.00291	CbGeAlD
Promethazine—Diarrhoea—Temozolomide—skin cancer	0.000553	0.00226	CcSEcCtD
Promethazine—Dry mouth—Docetaxel—skin cancer	0.000548	0.00224	CcSEcCtD
Promethazine—Confusional state—Docetaxel—skin cancer	0.000542	0.00222	CcSEcCtD
Promethazine—ABCB1—female reproductive system—skin cancer	0.00054	0.00281	CbGeAlD
Promethazine—Oedema—Docetaxel—skin cancer	0.000537	0.0022	CcSEcCtD
Promethazine—Anaphylactic shock—Docetaxel—skin cancer	0.000537	0.0022	CcSEcCtD
Promethazine—Dizziness—Temozolomide—skin cancer	0.000534	0.00219	CcSEcCtD
Promethazine—Shock—Docetaxel—skin cancer	0.000529	0.00216	CcSEcCtD
Promethazine—Pruritus—Fluorouracil—skin cancer	0.000527	0.00215	CcSEcCtD
Promethazine—Thrombocytopenia—Docetaxel—skin cancer	0.000526	0.00215	CcSEcCtD
Promethazine—Tachycardia—Docetaxel—skin cancer	0.000524	0.00215	CcSEcCtD
Promethazine—Rash—Temozolomide—skin cancer	0.000509	0.00208	CcSEcCtD
Promethazine—Diarrhoea—Fluorouracil—skin cancer	0.000509	0.00208	CcSEcCtD
Promethazine—Dermatitis—Temozolomide—skin cancer	0.000509	0.00208	CcSEcCtD
Promethazine—Headache—Temozolomide—skin cancer	0.000506	0.00207	CcSEcCtD
Promethazine—Hypotension—Docetaxel—skin cancer	0.000502	0.00205	CcSEcCtD
Promethazine—Dizziness—Fluorouracil—skin cancer	0.000492	0.00201	CcSEcCtD
Promethazine—Insomnia—Docetaxel—skin cancer	0.000486	0.00199	CcSEcCtD
Promethazine—Somnolence—Docetaxel—skin cancer	0.000478	0.00195	CcSEcCtD
Promethazine—Dyspepsia—Docetaxel—skin cancer	0.000473	0.00193	CcSEcCtD
Promethazine—Rash—Fluorouracil—skin cancer	0.000469	0.00192	CcSEcCtD
Promethazine—Dermatitis—Fluorouracil—skin cancer	0.000469	0.00192	CcSEcCtD
Promethazine—Decreased appetite—Docetaxel—skin cancer	0.000467	0.00191	CcSEcCtD
Promethazine—Headache—Fluorouracil—skin cancer	0.000466	0.00191	CcSEcCtD
Promethazine—Fatigue—Docetaxel—skin cancer	0.000463	0.00189	CcSEcCtD
Promethazine—Pain—Docetaxel—skin cancer	0.000459	0.00188	CcSEcCtD
Promethazine—Constipation—Docetaxel—skin cancer	0.000459	0.00188	CcSEcCtD
Promethazine—ABCB1—head—skin cancer	0.000451	0.00235	CbGeAlD
Promethazine—Feeling abnormal—Docetaxel—skin cancer	0.000443	0.00181	CcSEcCtD
Promethazine—Asthenia—Docetaxel—skin cancer	0.000385	0.00158	CcSEcCtD
Promethazine—Pruritus—Docetaxel—skin cancer	0.00038	0.00156	CcSEcCtD
Promethazine—Diarrhoea—Docetaxel—skin cancer	0.000368	0.0015	CcSEcCtD
Promethazine—Dizziness—Docetaxel—skin cancer	0.000355	0.00145	CcSEcCtD
Promethazine—Rash—Docetaxel—skin cancer	0.000339	0.00139	CcSEcCtD
Promethazine—Dermatitis—Docetaxel—skin cancer	0.000338	0.00138	CcSEcCtD
Promethazine—Headache—Docetaxel—skin cancer	0.000337	0.00138	CcSEcCtD
Promethazine—ABCB1—lymph node—skin cancer	0.000316	0.00164	CbGeAlD
Promethazine—CHRM2—Signaling Pathways—FOXO4—skin cancer	4.04e-05	0.000251	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—FOXO4—skin cancer	4.03e-05	0.000251	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RASA1—skin cancer	4.03e-05	0.000251	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RASA1—skin cancer	4.03e-05	0.000251	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SMO—skin cancer	3.98e-05	0.000247	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTCH1—skin cancer	3.98e-05	0.000247	CbGpPWpGaD
Promethazine—CALM3—Neuronal System—HRAS—skin cancer	3.95e-05	0.000245	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TERT—skin cancer	3.89e-05	0.000242	CbGpPWpGaD
Promethazine—CALM3—Signaling by NGF—HRAS—skin cancer	3.87e-05	0.000241	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTGER4—skin cancer	3.87e-05	0.000241	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTCH1—skin cancer	3.85e-05	0.000239	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SMO—skin cancer	3.85e-05	0.000239	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTCH1—skin cancer	3.85e-05	0.000239	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SMO—skin cancer	3.85e-05	0.000239	CbGpPWpGaD
Promethazine—CALM2—Neuronal System—HRAS—skin cancer	3.82e-05	0.000237	CbGpPWpGaD
Promethazine—CALM1—Neuronal System—HRAS—skin cancer	3.82e-05	0.000237	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ENO2—skin cancer	3.8e-05	0.000236	CbGpPWpGaD
Promethazine—CALM2—Signaling by NGF—HRAS—skin cancer	3.75e-05	0.000233	CbGpPWpGaD
Promethazine—CALM1—Signaling by NGF—HRAS—skin cancer	3.75e-05	0.000233	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTGER4—skin cancer	3.75e-05	0.000233	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTGER4—skin cancer	3.75e-05	0.000233	CbGpPWpGaD
Promethazine—CALM3—Signaling by NGF—IL6—skin cancer	3.71e-05	0.00023	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—NRAS—skin cancer	3.6e-05	0.000224	CbGpPWpGaD
Promethazine—CALM2—Signaling by NGF—IL6—skin cancer	3.59e-05	0.000223	CbGpPWpGaD
Promethazine—CALM1—Signaling by NGF—IL6—skin cancer	3.59e-05	0.000223	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ENO2—skin cancer	3.58e-05	0.000223	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ENO2—skin cancer	3.55e-05	0.000221	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—ERCC2—skin cancer	3.48e-05	0.000216	CbGpPWpGaD
Promethazine—CALM3—Disease—ERCC2—skin cancer	3.48e-05	0.000216	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—FOXO4—skin cancer	3.42e-05	0.000213	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—NRAS—skin cancer	3.42e-05	0.000213	CbGpPWpGaD
Promethazine—CALM2—Disease—ERCC2—skin cancer	3.37e-05	0.000209	CbGpPWpGaD
Promethazine—CALM1—Disease—ERCC2—skin cancer	3.37e-05	0.000209	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—NRAS—skin cancer	3.35e-05	0.000208	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—FOXO4—skin cancer	3.31e-05	0.000206	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—FOXO4—skin cancer	3.31e-05	0.000206	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—NRAS—skin cancer	3.27e-05	0.000204	CbGpPWpGaD
Promethazine—CALM3—Disease—TERT—skin cancer	3.26e-05	0.000203	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—NRAS—skin cancer	3.24e-05	0.000202	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—NRAS—skin cancer	3.24e-05	0.000202	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—BRAF—skin cancer	3.21e-05	0.0002	CbGpPWpGaD
Promethazine—CALM2—Disease—TERT—skin cancer	3.16e-05	0.000196	CbGpPWpGaD
Promethazine—CALM1—Disease—TERT—skin cancer	3.16e-05	0.000196	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—KRAS—skin cancer	3.1e-05	0.000193	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—BRAF—skin cancer	3.08e-05	0.000191	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—NRAS—skin cancer	3.02e-05	0.000188	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—ERCC2—skin cancer	2.99e-05	0.000186	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—KRAS—skin cancer	2.94e-05	0.000183	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—NRAS—skin cancer	2.92e-05	0.000181	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—NRAS—skin cancer	2.92e-05	0.000181	CbGpPWpGaD
Promethazine—CALM3—Metabolism—ERCC2—skin cancer	2.91e-05	0.000181	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—NRAS—skin cancer	2.9e-05	0.00018	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—KRAS—skin cancer	2.89e-05	0.000179	CbGpPWpGaD
Promethazine—CALM2—Metabolism—ERCC2—skin cancer	2.82e-05	0.000175	CbGpPWpGaD
Promethazine—CALM1—Metabolism—ERCC2—skin cancer	2.82e-05	0.000175	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—KRAS—skin cancer	2.82e-05	0.000175	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—NRAS—skin cancer	2.8e-05	0.000174	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—NRAS—skin cancer	2.8e-05	0.000174	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TERT—skin cancer	2.8e-05	0.000174	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—KRAS—skin cancer	2.79e-05	0.000173	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—KRAS—skin cancer	2.79e-05	0.000173	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.78e-05	0.000173	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—TP53—skin cancer	2.75e-05	0.000171	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TERT—skin cancer	2.75e-05	0.000171	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TERT—skin cancer	2.75e-05	0.000171	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TERT—skin cancer	2.74e-05	0.00017	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TERT—skin cancer	2.73e-05	0.00017	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TERT—skin cancer	2.7e-05	0.000168	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TERT—skin cancer	2.69e-05	0.000167	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—HRAS—skin cancer	2.63e-05	0.000164	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—KRAS—skin cancer	2.6e-05	0.000161	CbGpPWpGaD
Promethazine—CALM3—Disease—BRAF—skin cancer	2.58e-05	0.000161	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—TP53—skin cancer	2.57e-05	0.000159	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—IL6—skin cancer	2.52e-05	0.000157	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—KRAS—skin cancer	2.51e-05	0.000156	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—KRAS—skin cancer	2.51e-05	0.000156	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—HRAS—skin cancer	2.5e-05	0.000155	CbGpPWpGaD
Promethazine—CALM1—Disease—BRAF—skin cancer	2.5e-05	0.000155	CbGpPWpGaD
Promethazine—CALM2—Disease—BRAF—skin cancer	2.5e-05	0.000155	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—KRAS—skin cancer	2.5e-05	0.000155	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—TP53—skin cancer	2.48e-05	0.000154	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—TP53—skin cancer	2.48e-05	0.000154	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—HRAS—skin cancer	2.45e-05	0.000152	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—KRAS—skin cancer	2.41e-05	0.00015	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—KRAS—skin cancer	2.41e-05	0.00015	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—HRAS—skin cancer	2.4e-05	0.000149	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—IL6—skin cancer	2.39e-05	0.000149	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—HRAS—skin cancer	2.37e-05	0.000147	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—HRAS—skin cancer	2.37e-05	0.000147	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—NRAS—skin cancer	2.36e-05	0.000146	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—NRAS—skin cancer	2.32e-05	0.000144	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—NRAS—skin cancer	2.31e-05	0.000144	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—NRAS—skin cancer	2.31e-05	0.000143	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—NRAS—skin cancer	2.3e-05	0.000143	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—IL6—skin cancer	2.29e-05	0.000142	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TERT—skin cancer	2.28e-05	0.000142	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—NRAS—skin cancer	2.28e-05	0.000141	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	2.27e-05	0.000141	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—BRAF—skin cancer	2.21e-05	0.000138	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TERT—skin cancer	2.21e-05	0.000137	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TERT—skin cancer	2.21e-05	0.000137	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—HRAS—skin cancer	2.21e-05	0.000137	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ERCC2—skin cancer	2.21e-05	0.000137	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—BRAF—skin cancer	2.18e-05	0.000135	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—BRAF—skin cancer	2.17e-05	0.000135	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—BRAF—skin cancer	2.17e-05	0.000135	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—BRAF—skin cancer	2.16e-05	0.000134	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—BRAF—skin cancer	2.14e-05	0.000133	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—HRAS—skin cancer	2.14e-05	0.000133	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—HRAS—skin cancer	2.14e-05	0.000133	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—BRAF—skin cancer	2.13e-05	0.000133	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—HRAS—skin cancer	2.12e-05	0.000132	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—IL6—skin cancer	2.11e-05	0.000131	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PTGS2—skin cancer	2.09e-05	0.00013	CbGpPWpGaD
Promethazine—CALM3—Disease—PTGS2—skin cancer	2.09e-05	0.00013	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ERCC2—skin cancer	2.08e-05	0.000129	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ERCC2—skin cancer	2.06e-05	0.000128	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—HRAS—skin cancer	2.05e-05	0.000127	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—HRAS—skin cancer	2.05e-05	0.000127	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—IL6—skin cancer	2.04e-05	0.000127	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—IL6—skin cancer	2.04e-05	0.000127	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—KRAS—skin cancer	2.03e-05	0.000126	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—NRAS—skin cancer	2.02e-05	0.000126	CbGpPWpGaD
Promethazine—CALM2—Disease—PTGS2—skin cancer	2.02e-05	0.000125	CbGpPWpGaD
Promethazine—CALM1—Disease—PTGS2—skin cancer	2.02e-05	0.000125	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—KRAS—skin cancer	2e-05	0.000124	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—KRAS—skin cancer	1.99e-05	0.000124	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—KRAS—skin cancer	1.98e-05	0.000123	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—KRAS—skin cancer	1.98e-05	0.000123	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—KRAS—skin cancer	1.96e-05	0.000122	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	1.95e-05	0.000121	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—NRAS—skin cancer	1.93e-05	0.00012	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—NRAS—skin cancer	1.92e-05	0.00012	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—NRAS—skin cancer	1.86e-05	0.000116	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—NRAS—skin cancer	1.86e-05	0.000116	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—BRAF—skin cancer	1.81e-05	0.000112	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTGS2—skin cancer	1.8e-05	0.000112	CbGpPWpGaD
Promethazine—CALM3—Immune System—NRAS—skin cancer	1.76e-05	0.000109	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—BRAF—skin cancer	1.75e-05	0.000109	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—BRAF—skin cancer	1.75e-05	0.000109	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTGS2—skin cancer	1.75e-05	0.000109	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KRAS—skin cancer	1.74e-05	0.000108	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—HRAS—skin cancer	1.72e-05	0.000107	CbGpPWpGaD
Promethazine—CALM1—Immune System—NRAS—skin cancer	1.7e-05	0.000106	CbGpPWpGaD
Promethazine—CALM2—Immune System—NRAS—skin cancer	1.7e-05	0.000106	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—HRAS—skin cancer	1.7e-05	0.000105	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—HRAS—skin cancer	1.69e-05	0.000105	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTGS2—skin cancer	1.69e-05	0.000105	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTGS2—skin cancer	1.69e-05	0.000105	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—HRAS—skin cancer	1.69e-05	0.000105	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—HRAS—skin cancer	1.68e-05	0.000104	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—HRAS—skin cancer	1.67e-05	0.000103	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KRAS—skin cancer	1.67e-05	0.000103	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	1.66e-05	0.000103	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—KRAS—skin cancer	1.66e-05	0.000103	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—IL6—skin cancer	1.65e-05	0.000103	CbGpPWpGaD
Promethazine—CALM3—Disease—NRAS—skin cancer	1.62e-05	0.000101	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—IL6—skin cancer	1.62e-05	0.000101	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—IL6—skin cancer	1.62e-05	0.000101	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—IL6—skin cancer	1.61e-05	0.0001	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—IL6—skin cancer	1.61e-05	0.0001	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—KRAS—skin cancer	1.6e-05	9.96e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—KRAS—skin cancer	1.6e-05	9.96e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—IL6—skin cancer	1.59e-05	9.9e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—IL6—skin cancer	1.59e-05	9.88e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—NRAS—skin cancer	1.57e-05	9.76e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—NRAS—skin cancer	1.57e-05	9.76e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—skin cancer	1.55e-05	9.6e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—KRAS—skin cancer	1.51e-05	9.4e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—skin cancer	1.48e-05	9.2e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HRAS—skin cancer	1.48e-05	9.18e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—skin cancer	1.46e-05	9.1e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—skin cancer	1.46e-05	9.1e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—skin cancer	1.42e-05	8.8e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—skin cancer	1.41e-05	8.79e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—skin cancer	1.41e-05	8.75e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—skin cancer	1.4e-05	8.68e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NRAS—skin cancer	1.39e-05	8.65e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NRAS—skin cancer	1.37e-05	8.51e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NRAS—skin cancer	1.37e-05	8.49e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NRAS—skin cancer	1.36e-05	8.46e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—skin cancer	1.36e-05	8.46e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—skin cancer	1.36e-05	8.46e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NRAS—skin cancer	1.36e-05	8.44e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—skin cancer	1.35e-05	8.42e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—skin cancer	1.35e-05	8.4e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—skin cancer	1.35e-05	8.4e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—skin cancer	1.35e-05	8.37e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NRAS—skin cancer	1.34e-05	8.36e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NRAS—skin cancer	1.34e-05	8.33e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—skin cancer	1.32e-05	8.23e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—skin cancer	1.3e-05	8.1e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—skin cancer	1.3e-05	8.1e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—skin cancer	1.29e-05	7.99e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—skin cancer	1.25e-05	7.75e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—skin cancer	1.24e-05	7.73e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—skin cancer	1.24e-05	7.73e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—skin cancer	1.24e-05	7.69e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—skin cancer	1.23e-05	7.65e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—skin cancer	1.2e-05	7.44e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—skin cancer	1.19e-05	7.4e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—skin cancer	1.19e-05	7.4e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—skin cancer	1.19e-05	7.38e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—skin cancer	1.18e-05	7.32e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—skin cancer	1.18e-05	7.31e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—skin cancer	1.17e-05	7.29e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—skin cancer	1.17e-05	7.26e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—skin cancer	1.16e-05	7.19e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—skin cancer	1.15e-05	7.17e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—skin cancer	1.15e-05	7.14e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—skin cancer	1.15e-05	7.14e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NRAS—skin cancer	1.14e-05	7.06e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—skin cancer	1.14e-05	7.06e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NRAS—skin cancer	1.1e-05	6.83e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NRAS—skin cancer	1.1e-05	6.83e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—skin cancer	1.1e-05	6.83e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—skin cancer	1.1e-05	6.83e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—skin cancer	1.06e-05	6.62e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—skin cancer	1.05e-05	6.51e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—skin cancer	1.05e-05	6.5e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—skin cancer	1.04e-05	6.48e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—skin cancer	1.04e-05	6.45e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—skin cancer	1.03e-05	6.39e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—skin cancer	1.03e-05	6.37e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—skin cancer	1.02e-05	6.33e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—skin cancer	1e-05	6.23e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—skin cancer	1e-05	6.21e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—skin cancer	9.97e-06	6.19e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—skin cancer	9.93e-06	6.17e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—skin cancer	9.84e-06	6.11e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—skin cancer	9.81e-06	6.1e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—skin cancer	9.78e-06	6.08e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—skin cancer	9.75e-06	6.06e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—skin cancer	9.59e-06	5.96e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—skin cancer	9.57e-06	5.95e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—skin cancer	9.54e-06	5.93e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—skin cancer	9.51e-06	5.91e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—skin cancer	9.47e-06	5.88e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—skin cancer	9.47e-06	5.88e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—skin cancer	9.42e-06	5.85e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—skin cancer	9.39e-06	5.83e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—skin cancer	8.7e-06	5.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—skin cancer	8.41e-06	5.23e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—skin cancer	8.41e-06	5.23e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—skin cancer	8.32e-06	5.17e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—skin cancer	8.05e-06	5e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—skin cancer	8.05e-06	5e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—skin cancer	7.96e-06	4.95e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—skin cancer	7.7e-06	4.79e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—skin cancer	7.7e-06	4.79e-05	CbGpPWpGaD
